Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response
Author(s) -
Evan A. Thackaberry,
Cindy Farman,
Fiona Zhong,
Florence Lorget,
Karin Staflin,
Angelique Cercillieux,
Paul E. Miller,
Chris Schuetz,
Debby P. Chang,
Amin Famili,
Ann L. Daugherty,
Karthikan Rajagopal,
Vladimir Bantseev
Publication year - 2017
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-21334
Subject(s) - plga , toxicity , pharmacology , proinflammatory cytokine , cytokine , immune system , peripheral blood mononuclear cell , medicine , in vitro , inflammation , chemistry , immunology , biochemistry
Poly(lactic-co-glycolic) acid (PLGA) inserts have been successfully developed for the treatment of posterior eye disease as a means of reducing injection frequency of intravitreally administered therapeutics. PLGA microspheres are also of interest for the delivery of intravitreal drugs, since they offer the advantage of being easily injected without surgical procedures or large injectors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom